Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
144.42
+1.85 (1.30%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Glaukos Employees
Glaukos had 1,094 employees as of December 31, 2025. The number of employees increased by 99 or 9.95% compared to the previous year.
Employees
1,094
Change (1Y)
99
Growth (1Y)
9.95%
Revenue / Employee
$503,975
Profits / Employee
-$173,060
Market Cap
8.48B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,094 | 99 | 9.95% |
| Dec 31, 2024 | 995 | 88 | 9.70% |
| Dec 31, 2023 | 907 | 124 | 15.84% |
| Dec 31, 2022 | 783 | 56 | 7.70% |
| Dec 31, 2021 | 727 | 74 | 11.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| Bruker | 11,085 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
| Insulet | 5,400 |
| Penumbra | 4,700 |
GKOS News
- 1 day ago - Glaukos completes patient enrollment in Phase 2 study of GLK-321 - TheFly
- 1 day ago - Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis - Business Wire
- 9 days ago - Glaukos price target raised to $150 from $136 at Needham - TheFly
- 10 days ago - Glaukos Transcript: Truist Securities MedTech Conference 2026 - Transcripts
- 15 days ago - Glaukos price target raised to $162 from $140 at Citi - TheFly
- 23 days ago - Glaukos Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Glaukos Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 4 weeks ago - Glaukos Transcript: AGM 2026 - Transcripts